| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Multiple sclerosis | 5,169 | 721 | |
| Participate in clinical trial | 4 | 4 | |
| Fever/chills | 2 | 0 | |
| Amyotrophic lateral sclerosis | 1 | 1 | |
| Balance problems | 1 | 1 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Headaches | 27 | |
| Fatigue | 25 | |
| Elevated liver enzymes | 14 | |
| Nausea | 14 | |
| Heart rate low (bradycardia) | 12 | |
| Hair loss | 11 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 98 | |
| Moderate | 72 | |
| Mild | 148 | |
| None | 418 |
Member evaluations
helchr@hmnet.dk
evaluated on Apr 09, 2021
- Perceived effectiveness for multiple sclerosis: Moderate
- Side effects: Mild
Trans-am
evaluated on Sep 21, 2017
- Perceived effectiveness for multiple sclerosis: Moderate
- Side effects: Moderate
cleonard
evaluated on Jan 05, 2017
- Perceived effectiveness for relapse MS (exacerbation): Moderate
- Side effects: None